Kalamazoo, MI, United States of America

Loksidh Devi Ganorkar

This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2013.


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Loksidh Devi Ganorkar: Innovator in Pharmaceutical Composition

Introduction

Loksidh Devi Ganorkar is a notable inventor based in Kalamazoo, MI (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of sustained-release tablet compositions. Her innovative work has the potential to enhance the delivery and effectiveness of medications.

Latest Patents

Loksidh holds a patent for a sustained-release pharmaceutical composition of pramipexole. This composition is designed in the form of an orally deliverable tablet that comprises a water-soluble salt of pramipexole. The formulation is dispersed in a matrix that includes a hydrophilic polymer and a starch, which has a tensile strength of at least about 0.15 kN at a solid fraction representative of the tablet. This patent showcases her expertise in creating effective drug delivery systems.

Career Highlights

Loksidh is currently employed at Boehringer Ingelheim International GmbH, where she continues to work on innovative pharmaceutical solutions. Her role at the company allows her to collaborate with other talented professionals in the industry, further advancing her research and development efforts.

Collaborations

Some of her coworkers include Joseph Peter Reo and John Mark Heimlich. Their collaboration contributes to a dynamic work environment that fosters innovation and creativity in pharmaceutical research.

Conclusion

Loksidh Devi Ganorkar is a pioneering inventor whose work in sustained-release pharmaceutical compositions is making a significant impact in the field. Her contributions are essential for the advancement of effective medication delivery systems.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…